<DOC>
	<DOCNO>NCT02139761</DOCNO>
	<brief_summary>Cocaine continue one widely use substance abuse around world . In US , estimate 1.4 million individual ( 0.5 % ) &gt; 12 year current ( past month ) cocaine user 2011 . Currently , FDA-approved pharmacologic treatment available cocaine addiction ; thus , remain serious public health problem without effective pharmacological treatment . A promising lead towards effective treatment come recent find pretreatment oral l-tetrahydropalmitine ( l-THP ) rat attenuate cocaine seek associate cocaine challenge , motor effect . This finding stimulate group test pharmacokinetics safety l-THP phase I study people cocaine use . Preliminary finding show l-THP safe well tolerated cocaine user , adverse interaction cocaine . This study test efficacy safety l-THP abstinence cocaine addiction phase II pilot study ( N=24 ) . Secondarily , examine effect medication crave .</brief_summary>
	<brief_title>L-tetrahydropalmatine ( l-THP ) Treatment Cocaine Use Disorder</brief_title>
	<detailed_description />
	<mesh_term>Cocaine</mesh_term>
	<mesh_term>Tetrahydropalmatine</mesh_term>
	<criteria>men nonpregnant/nonnursing woman age 18 50 year meet criterion DSM5 cocaine use disorder selfreported cocaine use ( intranasal , IV smoke ) average least weekly prior six month positive urine drug test cocaine prior month HIV seronegative EKG without clinically significant abnormality normal blood pressure ( systolic : 90140 mmHg ; diastolic : 5090 mmHg ) rest heart rate ( 6090 bpm ) ability adhere study restriction examination schedule woman reproductive potential must agree use one follow birth control method ( oral contraceptive , condom spermicide , diaphragm , intrauterine device ) study 2 week last medication dose . participation investigational drug trial clinical drug trial within 45 day study entry history clinically significant adverse reaction hypersensitivity cocaine lTHP inability communicate cooperate investigator currently take prescribe psychoactive medication , e.g. , anti depressant , antipsychotic , mood stabilizer current clinically significant medical problem might interfere safe study participation . This include pheochromocytoma , untreated hyperthyroidism , dehydration , fever , coronary artery disease , uncorrected congenital heart defect , seizure , electrolyte imbalance , uncontrolled diabetes mellitus , porphyria variegate , superventricular tachycardia , atrial fibrillation , cardiomyopathy , uncontrolled hypertension . current Axis I Major Depression , Schizophrenia , Bipolar Disorder . score 10/12 Evaluation Sign Consent ( ESC )</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>50 Years</maximum_age>
	<verification_date>August 2016</verification_date>
	<keyword>Cocaine</keyword>
	<keyword>Treatment</keyword>
</DOC>